Abstract Publications
All accepted abstracts will be available in a
Journal for ImmunoTherapy of Cancer (JITC) supplement, which will be published on
Nov. 7 at 8 a.m. EST. Full regular and late-breaking abstract content is embargoed until the abstract supplement has published. The link to the abstract supplement will be posted here when available.